Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endosomal and lysosomal nucleic acids refer to DNA and RNA molecules located within the endocytic pathway, where they serve as ligands for Pattern Recognition Receptors (PRRs), specifically Toll-like receptors 3, 7, 8, and 9 (Saas et al., 2023). These nucleic acids can be of exogenous origin, such as viral or bacterial genomes, or endogenous origin, such as self-DNA/RNA released during cell death or through autophagy. The recognition of these molecules is a fundamental component of the innate immune response, triggering the production of type I interferons and other pro-inflammatory cytokines to combat infection. However, the persistent presence or improper sensing of self-nucleic acids in these compartments is a hallmark of autoimmune diseases like systemic lupus erythematosus (SLE) and Sjögren's syndrome. Therapeutic agents like hydroxychloroquine target these nucleic acids by binding to them directly or by neutralizing the acidic environment of the endolysosome, thereby preventing the activation of the TLR signaling cascade and reducing chronic inflammation (Schrezenmeier & Dörner, 2020).
Inhibition of Toll-like receptor (TLR) signaling through direct binding to nucleic acids (masking them from receptors) and elevation of endosomal/lysosomal pH, which prevents the proteolytic activation of TLRs and the processing of their ligands (Schrezenmeier & Dörner, 2020; Kuznik et al., 2011).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endosomal and lysosomal nucleic acid.